The Current Ratio of Clovis Oncology Inc (CLVS) is
1.58.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date |
Value |
| 2021-12-31 |
1.58
|
| 2020-12-31 |
1.68
|
| 2019-12-31 |
2.75
|
| 2018-12-31 |
4.55
|
| 2017-12-31 |
7.69
|
| 2016-12-31 |
3.26
|
| 2015-12-31 |
7.14
|
| 2014-12-31 |
10.28
|
| 2013-12-31 |
15.65
|
| 2012-12-31 |
11.88
|
| Ticker |
Name |
Value |
|
ADAP
|
Adaptimmune Therapeutics PLC
|
2.92
|
|
CTMX
|
CytomX Therapeutics, Inc.
|
3.09
|
|
HARP
|
Harpoon Therapeutics Inc
|
1.04
|
|
KDNY
|
Chinook Therapeutics Inc
|
7.59
|
|
SYRS
|
Syros Pharmaceuticals Inc
|
3.95
|
|
VYGR
|
Voyager Therapeutics, Inc.
|
7.64
|
|
AMGN
|
Amgen Inc
|
1.14
|
|
ANAB
|
AnaptysBio, Inc.
|
5.61
|
|
CMRX
|
Chimerix Inc
|
5.70
|
|
RIGL
|
Rigel Pharmaceuticals, Inc.
|
2.42
|
|
EPZM
|
Epizyme Inc
|
4.56
|
|
KALV
|
KalVista Pharmaceuticals, Inc.
|
5.58
|
|
SGTX
|
Sigilon Therapeutics Inc
|
2.40
|
|
950160.KQ
|
Kolon TissueGene Inc
|
0.24
|
|
950220.KQ
|
Neoimmunetech Inc
|
3.08
|
|
ABBV
|
AbbVie Inc.
|
0.67
|
|
DVAX
|
Dynavax Technologies Corp
|
10.80
|
|
MRUS
|
Merus NV
|
6.54
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
2.90
|
|
DTIL
|
Precision Biosciences, Inc
|
13.32
|
|
SURF
|
Surface Oncology Inc
|
7.94
|
|
ACIU
|
AC Immune AG
|
1.02
|
|
AGEN
|
Agenus Inc
|
0.41
|
|
GTHX
|
G1 Therapeutics Inc
|
3.87
|
|
MTEM
|
Molecular Templates Inc
|
0.97
|
|
VNDA
|
Vanda Pharmaceuticals Inc
|
2.39
|
|
AFMD
|
Affimed NV
|
3.25
|
|
GILD
|
Gilead Sciences, Inc.
|
1.55
|
|
IDYA
|
IDEAYA Biosciences, Inc.
|
11.34
|
|
INBX
|
Inhibrx Biosciences Inc
|
3.93
|
|
JNCE
|
Jounce Therapeutics Inc
|
8.37
|
|
MRNA
|
Moderna, Inc.
|
3.29
|
|
950200.KQ
|
Psomagen Inc
|
1.67
|
|
CNTG
|
Centogene NV
|
1.02
|
|
KPTI
|
Karyopharm Therapeutics Inc.
|
1.12
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
4.13
|
|
XBIT
|
XBiotech Inc
|
16.01
|